XENE
Xenon Pharmaceuticals Inc
2 of the 83 super-investors we track hold XENE, worth a combined $99M per their latest 13F filings. The largest position: Stanley Druckenmiller at 0.3% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 43 of 100 (how strongly the cohort backs it) — ranked #90 of 742 stocks.
Why super-investors own XENE
XENE is held by 2 super-investors in our cohort, with a combined position value of $99M. The highest-conviction owner is Stanley Druckenmiller at 0.3% of their portfolio. Cohort ownership has grown from 1 to 2 over the last four quarters — net interest is rising.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2018Q3 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | <0.1% | 32q | $85M | 1,401,242 |
| 2 | Stanley Druckenmiller | 0.3% | 2q | $14M | 238,600 |
Owners of XENE also hold
Long US equity 13F-HR filings only. CUSIP 98420N105. Not investment advice.